Key Takeaway: Telix Pharmaceuticals will announce its full year results for 2023 on February 22, 2024. An investor webcast is scheduled for February 23, 2024, allowing stakeholders to engage directly with the company. This event highlights Telix's commitment to transparency and investor relations.
Market Sentiment Analysis
POSITIVE FACTORS
Telix is set to release its full year results, indicating transparency.
The scheduled investor webcast shows commitment to stakeholder engagement.
The event provides an opportunity for investors to gain insights.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+13%
120-day peak, hindsight
Typical move
7%
average across 7 past catalysts
Lead asset
131I-IPA
Phase 1 · Neoplastic Disease
Full Press Release Details
Melbourne (Australia) | 7 February 2024
Telix today advises that it will release its full year results and Annual Report for the period ended 31 December 2023 on Thursday 22 February 2024.
An investor webcast and conference call will be held at 9.00am, Friday 23 February 2024 AEDT (5.00pm, Thursday 22 February 2024 EST).